基于荧光的间充质干细胞活体示踪的单模态和多模态成像。
Fluorescence-Based Mono- and Multimodal Imaging for In Vivo Tracking of Mesenchymal Stem Cells.
机构信息
KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea.
Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Woman's University, Seoul 03760, Republic of Korea.
出版信息
Biomolecules. 2023 Dec 13;13(12):1787. doi: 10.3390/biom13121787.
The advancement of stem cell therapy has offered transformative therapeutic outcomes for a wide array of diseases over the past decades. Consequently, stem cell tracking has become significant in revealing the mechanisms of action and ensuring safe and effective treatments. Fluorescence stands out as a promising choice for stem cell tracking due to its myriad advantages, including high resolution, real-time monitoring, and multi-fluorescence detection. Furthermore, combining fluorescence with other tracking modalities-such as bioluminescence imaging (BLI), positron emission tomography (PET), photoacoustic (PA), computed tomography (CT), and magnetic resonance (MR)-can address the limitations of single fluorescence detection. This review initially introduces stem cell tracking using fluorescence imaging, detailing various labeling strategies such as green fluorescence protein (GFP) tagging, fluorescence dye labeling, and nanoparticle uptake. Subsequently, we present several combinations of strategies for efficient and precise detection.
在过去的几十年中,干细胞治疗的进步为广泛的疾病提供了变革性的治疗效果。因此,干细胞示踪对于揭示作用机制和确保安全有效的治疗方法变得非常重要。由于具有高分辨率、实时监测和多荧光检测等多种优势,荧光技术成为干细胞示踪的一种有前途的选择。此外,将荧光与其他示踪方式(如生物发光成像(BLI)、正电子发射断层扫描(PET)、光声(PA)、计算机断层扫描(CT)和磁共振(MR))相结合,可以解决单一荧光检测的局限性。本综述首先介绍了使用荧光成像的干细胞示踪,详细描述了各种标记策略,如绿色荧光蛋白(GFP)标记、荧光染料标记和纳米颗粒摄取。随后,我们提出了几种用于高效和精确检测的策略组合。